China SXT Pharmaceuticals (SXTC) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on China SXT Pharmaceuticals (SXTC) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.20 of bullish evidence against -0.51 bearish.

China SXT Pharmaceuticals last closed at $0.15.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for SXTC so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

China SXT Pharmaceuticals is classified under Health Care / Pharmaceuticals.

StockMap tracks China SXT Pharmaceuticals as one of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite China SXT Pharmaceuticals ranks 137th of 151 in the group, against a group median of -0.08.